Singh Jasvinder A
Arthritis Res Ther. 2014 Mar 29;16(2):R82. doi: 10.1186/ar4524.
Limited literature exists for qualitative studies of medication adherence in gout, especially in African-Americans. The aim of this study was to examine the facilitators and barriers to adherence to urate-lowering therapy (ULT) in African-Americans with gout.
In this study, nine nominal groups lasting 1 to 1.5 hours each were conducted in African-Americans with gout, six with low ULT and three with high ULT adherence (medication possession ratios of <0.80 or ≥0.80, respectively). Patients presented, discussed, combined and rank ordered their concerns. A qualitative analysis was performed.
This study included 43 patients with mean age 63.9 years (standard deviation, 9.9), 67% men, who participated in nine nominal groups (seven in men, two in women): African-American men (n = 30); African-American women (n = 13). The main facilitators to ULT adherence (three groups) were the recognition of the need to take ULT regularly to prevent gout flares, prevent pain from becoming chronic/severe and to have less dietary restriction; the lack of side effects from ULT; trust in physicians; and avoiding the need to seek emergent/urgent care for flares. Patients achieved high ULT adherence by organizing their pills using the pillbox and the incorporation of ULT intake into their routine to prevent forgetting. The main barriers to optimal ULT adherence were (six groups): doubts about effectiveness of ULT, concerns about cost and side effects, concomitant medications, forgetfulness, refilling the prescriptions on time, pill size and difficulty in swallowing, competing priorities, patient preference for alternative medicines (that is, cherry juice) and frequent travel.
Identification of facilitators and barriers to high ULT adherence in African-Americans with gout in this study lays the foundation for designing interventions to improve ULT adherence in racial minorities.
关于痛风患者药物依从性的定性研究文献有限,尤其是在非裔美国人中。本研究的目的是探讨非裔美国痛风患者坚持降尿酸治疗(ULT)的促进因素和障碍。
在本研究中,对非裔美国痛风患者进行了9次名义小组讨论,每次持续1至1.5小时,其中6次小组讨论的患者ULT依从性低,3次小组讨论的患者ULT依从性高(药物持有率分别<0.80或≥0.80)。患者提出、讨论、合并并对他们关心的问题进行排序。进行了定性分析。
本研究纳入了43例患者,平均年龄63.9岁(标准差9.9),67%为男性,他们参加了9次名义小组讨论(7次男性,2次女性):非裔美国男性(n = 30);非裔美国女性(n = 13)。ULT依从性的主要促进因素(3个小组)包括:认识到需要定期服用ULT以预防痛风发作、防止疼痛变为慢性/严重以及减少饮食限制;ULT无副作用;对医生的信任;以及避免因发作而寻求紧急护理。患者通过使用药盒整理药片并将ULT摄入纳入日常安排以防止遗忘,从而实现了较高的ULT依从性。ULT最佳依从性的主要障碍是(6个小组):对ULT有效性的怀疑、对成本和副作用的担忧、合并用药、健忘、按时重新开药、药片大小和吞咽困难、相互竞争的优先事项、患者对替代药物(即樱桃汁)的偏好以及频繁旅行。
本研究确定了非裔美国痛风患者ULT高依从性的促进因素和障碍,为设计改善少数族裔ULT依从性的干预措施奠定了基础。